VIIV HEALTHCARE PTY LTD

πŸ‡¦πŸ‡ΊAustralia
Ownership
-
Employees
-
Market Cap
-
Website

Relative Bioavailability Study With BMS-955176

Phase 1
Completed
Conditions
Interventions
First Posted Date
2014-03-26
Last Posted Date
2017-09-11
Lead Sponsor
ViiV Healthcare
Target Recruit Count
47
Registration Number
NCT02095886
Locations
πŸ‡¬πŸ‡§

GSK Investigational Site, Nottingham, United Kingdom

Study to Evaluate the Drug Interaction Between Dolutegravir (DTG) and Daclatasvir (DCV) in Healthy Adult Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2014-03-10
Last Posted Date
2014-06-09
Lead Sponsor
ViiV Healthcare
Target Recruit Count
12
Registration Number
NCT02082808
Locations
πŸ‡ΊπŸ‡Έ

GSK Investigational Site, Overland Park, Kansas, United States

Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)

First Posted Date
2014-03-03
Last Posted Date
2017-12-15
Lead Sponsor
ViiV Healthcare
Target Recruit Count
127
Registration Number
NCT02076178
Locations
πŸ‡ΊπŸ‡Έ

GSK Investigational Site, Newport News, Virginia, United States

ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection

First Posted Date
2014-03-03
Last Posted Date
2022-10-06
Lead Sponsor
ViiV Healthcare
Target Recruit Count
4
Registration Number
NCT02075593
Locations
πŸ‡ͺπŸ‡Έ

GSK Investigational Site, Madrid, Spain

A Prospective, Non-interventional Study of the Use of Dolutegravir as Part of Combination Antiretroviral Therapy in Routine Daily Practice in Germany

First Posted Date
2014-03-03
Last Posted Date
2018-08-13
Lead Sponsor
ViiV Healthcare
Target Recruit Count
411
Registration Number
NCT02076386
Locations
πŸ‡©πŸ‡ͺ

GSK Investigational Site, Weimar, Germany

Effect of Dolutegravir on Metformin Pharmacokinetics in Healthy Adult Subjects

First Posted Date
2014-02-17
Last Posted Date
2014-05-26
Lead Sponsor
ViiV Healthcare
Target Recruit Count
30
Registration Number
NCT02064374
Locations
πŸ‡ΊπŸ‡Έ

GSK Investigational Site, Overland Park, Kansas, United States

DDI Study of BMS-663068 With Etravirine (ETR) and/or Darunavir (DVR) + Ritonavir (RTV)

First Posted Date
2014-02-14
Last Posted Date
2017-08-08
Lead Sponsor
ViiV Healthcare
Target Recruit Count
42
Registration Number
NCT02063360

A Study to Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult Subjects

First Posted Date
2014-02-11
Last Posted Date
2014-07-16
Lead Sponsor
ViiV Healthcare
Target Recruit Count
24
Registration Number
NCT02059031
Locations
πŸ‡ΊπŸ‡Έ

GSK Investigational Site, Overland Park, Kansas, United States

Study to Evaluate the Effect of GSK1265744 on Cardiac Conduction

First Posted Date
2014-01-06
Last Posted Date
2014-06-16
Lead Sponsor
ViiV Healthcare
Target Recruit Count
42
Registration Number
NCT02027454
Locations
πŸ‡ΊπŸ‡Έ

GSK Investigational Site, Overland Park, Kansas, United States

Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-10-23
Last Posted Date
2014-01-27
Lead Sponsor
ViiV Healthcare
Target Recruit Count
16
Registration Number
NCT01967771
Locations
πŸ‡ΊπŸ‡Έ

GSK Investigational Site, Overland Park, Kansas, United States

Β© Copyright 2024. All Rights Reserved by MedPath